Genentech Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
XOMA | A | XOMA Corporation | 3.62 | |
EXEL | A | Exelixis, Inc. | 0.13 | |
CRIS | B | Curis, Inc. | -5.98 | |
ASND | C | Ascendis Pharma A/S | -0.51 | |
SNDX | D | Syndax Pharmaceuticals, Inc. | 1.51 | |
XENE | D | Xenon Pharmaceuticals Inc. | -1.07 | |
OTLK | D | Outlook Therapeutics, Inc. | -1.45 | |
LXRX | F | Lexicon Pharmaceuticals, Inc. | 1.23 | |
KA | F | Kineta, Inc. | 8.41 | |
SGMO | F | Sangamo BioSciences, Inc. | 5.44 |
Related Industries: Biotechnology Drug Manufacturers - Major
Related Stock Lists:
Biotechnology
Life Sciences
Biopharmaceutical
Cancer
Diabetes
Medicine
Monoclonal Antibodies
Solid Tumors
Acne
Antibodies
Breast Cancer
Cancer Cell
Cardiovascular Disease
Drug Discovery
Hypertension
Lung Cancer
Multiple Myeloma
Non Small Cell Lung Cancer
Osteoarthritis
Prostate Cancer
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MEDI | C | Harbor Health Care ETF | 16.22 | |
BBP | D | BioShares Biotechnology Products Fund | 7.2 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 5.61 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.15 | |
SYNB | C | Putnam BioRevolution ETF | 3.93 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Major
Related Stock Lists:
Biotechnology
Life Sciences
Biopharmaceutical
Cancer
Diabetes
Medicine
Monoclonal Antibodies
Solid Tumors
Acne
Antibodies
Breast Cancer
Cancer Cell
Cardiovascular Disease
Drug Discovery
Hypertension
Lung Cancer
Multiple Myeloma
Non Small Cell Lung Cancer
Osteoarthritis
Prostate Cancer
- Genentech
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of September 2017, Genentech employed 15,064 people.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles